{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:04:43Z","timestamp":1793293483504,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["212300410266"],"award-info":[{"award-number":["212300410266"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Construction Project of Henan Medical Science and Technology Tackling Plan","award":["2018020101"],"award-info":[{"award-number":["2018020101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-025-00620-3","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:23:05Z","timestamp":1741191785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["HOXB4\/METTL7B cascade mediates malignant phenotypes of hepatocellular carcinoma through TKT m6A modification"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1718-8156","authenticated-orcid":false,"given":"Enshuang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"620_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(18)30010-2.","journal-title":"Lancet"},{"key":"620_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67:358\u201380. https:\/\/doi.org\/10.1002\/hep.29086.","journal-title":"Hepatology"},{"key":"620_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12943-017-0712-x","volume":"16","author":"G Khemlina","year":"2017","unstructured":"Khemlina G, Ikeda S, Kurzrock R. The biology of hepatocellular carcinoma: implications for genomic and immune therapies. Mol Cancer. 2017;16:149. https:\/\/doi.org\/10.1186\/s12943-017-0712-x.","journal-title":"Mol Cancer"},{"key":"620_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1134\/S0006297917080016","volume":"82","author":"MV Novikova","year":"2017","unstructured":"Novikova MV, Khromova NV, Kopnin PB. Components of the hepatocellular carcinoma microenvironment and their role in tumor progression. Biochem (Mosc). 2017;82:861\u201373. https:\/\/doi.org\/10.1134\/S0006297917080016.","journal-title":"Biochem (Mosc)"},{"key":"620_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/1878-0261.12639","volume":"14","author":"C Yang","year":"2020","unstructured":"Yang C, Huang X, Liu Z, Qin W, Wang C. Metabolism-associated molecular classification of hepatocellular carcinoma. Mol Oncol. 2020;14:896\u2013913. https:\/\/doi.org\/10.1002\/1878-0261.12639.","journal-title":"Mol Oncol"},{"key":"620_CR6","doi-asserted-by":"publisher","unstructured":"Jin Z, et al. Comprehensive analysis of HOX family members as novel diagnostic and prognostic markers for hepatocellular carcinoma. J Oncol. 2022;2022(5758601). https:\/\/doi.org\/10.1155\/2022\/5758601.","DOI":"10.1155\/2022\/5758601"},{"key":"620_CR7","doi-asserted-by":"publisher","first-page":"e12835","DOI":"10.1111\/cpr.12835","volume":"53","author":"L Wang","year":"2020","unstructured":"Wang L, et al. HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway. Cell Prolif. 2020;53:e12835. https:\/\/doi.org\/10.1111\/cpr.12835.","journal-title":"Cell Prolif"},{"key":"620_CR8","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.7150\/thno.41712","volume":"10","author":"Y Dang","year":"2020","unstructured":"Dang Y, et al. Interleukin 1beta-mediated HOXC10 overexpression promotes hepatocellular carcinoma metastasis by upregulating PDPK1 and VASP. Theranostics. 2020;10:3833\u201348. https:\/\/doi.org\/10.7150\/thno.41712.","journal-title":"Theranostics"},{"key":"620_CR9","doi-asserted-by":"publisher","first-page":"803493","DOI":"10.3389\/fonc.2022.803493","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, et al. HOXB4 Mis-Regulation induced by Microcystin-LR and correlated with immune infiltration is unfavorable to colorectal Cancer prognosis. Front Oncol. 2022;12:803493. https:\/\/doi.org\/10.3389\/fonc.2022.803493.","journal-title":"Front Oncol"},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-021-03411-6","volume":"12","author":"D Lei","year":"2021","unstructured":"Lei D, Yang WT, Zheng PS. HOXB4 inhibits the proliferation and tumorigenesis of cervical cancer cells by downregulating the activity of Wnt\/beta-catenin signaling pathway. Cell Death Dis. 2021;12:105. https:\/\/doi.org\/10.1038\/s41419-021-03411-6.","journal-title":"Cell Death Dis"},{"key":"620_CR11","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.3892\/ol.2017.6825","volume":"14","author":"G Zhou","year":"2017","unstructured":"Zhou G, Liu X, Xiong B, Sun Y. Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13. Oncol Lett. 2017;14:4625\u201332. https:\/\/doi.org\/10.3892\/ol.2017.6825.","journal-title":"Oncol Lett"},{"key":"620_CR12","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3892\/ijo.2017.4151","volume":"51","author":"R Bonfim-Silva","year":"2017","unstructured":"Bonfim-Silva R, et al. Functional analysis of HOXA10 and HOXB4 in human Medulloblastoma cell lines. Int J Oncol. 2017;51:1929\u201340. https:\/\/doi.org\/10.3892\/ijo.2017.4151.","journal-title":"Int J Oncol"},{"key":"620_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2017.94","volume":"17","author":"CA Bradley","year":"2017","unstructured":"Bradley CA, Immunotherapy. CD8(+) T cells - burn fat, get fit. Nat Rev Cancer. 2017;17:635. https:\/\/doi.org\/10.1038\/nrc.2017.94.","journal-title":"Nat Rev Cancer"},{"key":"620_CR14","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1038\/s41467-022-35469-x","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, et al. PRDM1\/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nat Commun. 2022;13:7677. https:\/\/doi.org\/10.1038\/s41467-022-35469-x.","journal-title":"Nat Commun"},{"key":"620_CR15","doi-asserted-by":"publisher","first-page":"e1258503","DOI":"10.1080\/2162402X.2016.1258503","volume":"6","author":"M Schroder","year":"2017","unstructured":"Schroder M, et al. Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical screening. Oncoimmunology. 2017;6:e1258503. https:\/\/doi.org\/10.1080\/2162402X.2016.1258503.","journal-title":"Oncoimmunology"},{"key":"620_CR16","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1053\/j.gastro.2008.02.090","volume":"134","author":"HB El-Serag","year":"2008","unstructured":"El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752\u201363. https:\/\/doi.org\/10.1053\/j.gastro.2008.02.090.","journal-title":"Gastroenterology"},{"key":"620_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x.","journal-title":"Signal Transduct Target Ther"},{"key":"620_CR18","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613. https:\/\/doi.org\/10.1016\/j.biopha.2019.108613.","journal-title":"Biomed Pharmacother"},{"key":"620_CR19","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional Silencing of SOCS2. Hepatology. 2018;67:2254\u201370. https:\/\/doi.org\/10.1002\/hep.29683.","journal-title":"Hepatology"},{"key":"620_CR20","doi-asserted-by":"publisher","first-page":"665192","DOI":"10.3389\/fonc.2021.665192","volume":"11","author":"TH Li","year":"2021","unstructured":"Li TH, et al. Identification METTL18 as a potential prognosis biomarker and associated with immune infiltrates in hepatocellular carcinoma. Front Oncol. 2021;11:665192. https:\/\/doi.org\/10.3389\/fonc.2021.665192.","journal-title":"Front Oncol"},{"key":"620_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"JZ Ma","year":"2017","unstructured":"Ma JZ, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65:529\u201343. https:\/\/doi.org\/10.1002\/hep.28885.","journal-title":"Hepatology"},{"key":"620_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13046-019-1131-1","volume":"38","author":"Z Qin","year":"2019","unstructured":"Qin Z, et al. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner. J Exp Clin Cancer Res. 2019;38:154. https:\/\/doi.org\/10.1186\/s13046-019-1131-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"620_CR23","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1002\/ctm2.1095","volume":"12","author":"D Jia","year":"2022","unstructured":"Jia D, et al. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative Pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids. Clin Transl Med. 2022;12:e1095. https:\/\/doi.org\/10.1002\/ctm2.1095.","journal-title":"Clin Transl Med"},{"key":"620_CR24","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1038\/s12276-023-01060-7","volume":"55","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice. Exp Mol Med. 2023;55:2162\u201376. https:\/\/doi.org\/10.1038\/s12276-023-01060-7.","journal-title":"Exp Mol Med"},{"key":"620_CR25","doi-asserted-by":"publisher","first-page":"111824","DOI":"10.1016\/j.biopha.2021.111824","volume":"141","author":"M Ashrafizadeh","year":"2021","unstructured":"Ashrafizadeh M, et al. New insight towards development of Paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother. 2021;141:111824. https:\/\/doi.org\/10.1016\/j.biopha.2021.111824.","journal-title":"Biomed Pharmacother"},{"key":"620_CR26","first-page":"461","volume":"22","author":"Y Ishii","year":"2003","unstructured":"Ishii Y, Nakasato Y, Kobayashi S, Yamazaki Y, Aoki T. A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma. J Exp Clin Cancer Res. 2003;22:461\u201370.","journal-title":"J Exp Clin Cancer Res"},{"key":"620_CR27","doi-asserted-by":"publisher","first-page":"1070961","DOI":"10.3389\/fimmu.2022.1070961","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Han J, Yang Y, Chen Y. PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy. Front Immunol. 2022;13:1070961. https:\/\/doi.org\/10.3389\/fimmu.2022.1070961.","journal-title":"Front Immunol"},{"key":"620_CR28","doi-asserted-by":"publisher","first-page":"1225821","DOI":"10.3389\/fphar.2023.1225821","volume":"14","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Ruff SM, Pawlik TM. The effect of liver disease on hepatic microenvironment and implications for immune therapy. Front Pharmacol. 2023;14:1225821. https:\/\/doi.org\/10.3389\/fphar.2023.1225821.","journal-title":"Front Pharmacol"},{"key":"620_CR29","doi-asserted-by":"publisher","unstructured":"Paco A, de Bessa Garcia A S, Freitas R. Methylation in HOX clusters and its applications in Cancer therapy. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9071613.","DOI":"10.3390\/cells9071613"},{"key":"620_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic Silencing of ETS1. Mol Cancer. 2019;18:127. https:\/\/doi.org\/10.1186\/s12943-019-1053-8.","journal-title":"Mol Cancer"},{"key":"620_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C, Where. When, and how: Context-Dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74:640\u201350. https:\/\/doi.org\/10.1016\/j.molcel.2019.04.025.","journal-title":"Mol Cell"},{"key":"620_CR32","doi-asserted-by":"publisher","unstructured":"Dai YZ, et al. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner. Cell Mol Biol Lett. 2022;27. https:\/\/doi.org\/10.1186\/s11658-022-00342-8.","DOI":"10.1186\/s11658-022-00342-8"},{"key":"620_CR33","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1002\/ctm2.686","volume":"12","author":"Y Lei","year":"2022","unstructured":"Lei Y, et al. Protein arginine methyltransferase 3 promotes Glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A. Clin Transl Med. 2022;12:e686. https:\/\/doi.org\/10.1002\/ctm2.686.","journal-title":"Clin Transl Med"},{"key":"620_CR34","doi-asserted-by":"publisher","first-page":"909189","DOI":"10.3389\/fimmu.2022.909189","volume":"13","author":"C Luo","year":"2022","unstructured":"Luo C, et al. A whole exon Screening-Based score model predicts prognosis and immune checkpoint inhibitor therapy effects in Low-Grade glioma. Front Immunol. 2022;13:909189. https:\/\/doi.org\/10.3389\/fimmu.2022.909189.","journal-title":"Front Immunol"},{"key":"620_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1530\/JME-18-0261","volume":"63","author":"D Ye","year":"2019","unstructured":"Ye D, et al. METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition. J Mol Endocrinol. 2019;63:51\u201361. https:\/\/doi.org\/10.1530\/JME-18-0261.","journal-title":"J Mol Endocrinol"},{"key":"620_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fphar.2020.00178","volume":"11","author":"D Liu","year":"2020","unstructured":"Liu D, et al. METTL7B is required for Cancer cell proliferation and tumorigenesis in Non-Small cell lung Cancer. Front Pharmacol. 2020;11:178. https:\/\/doi.org\/10.3389\/fphar.2020.00178.","journal-title":"Front Pharmacol"},{"key":"620_CR37","doi-asserted-by":"publisher","first-page":"148501","DOI":"10.1016\/j.gene.2024.148501","volume":"919","author":"C Yadav","year":"2024","unstructured":"Yadav C, et al. Role of HOX genes in cancer progression and their therapeutical aspects. Gene. 2024;919:148501. https:\/\/doi.org\/10.1016\/j.gene.2024.148501.","journal-title":"Gene"},{"key":"620_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12885-020-06725-4","volume":"20","author":"N Li","year":"2020","unstructured":"Li N, Gou JH, Xiong J, You JJ, Li ZY. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS. BMC Cancer. 2020;20:222. https:\/\/doi.org\/10.1186\/s12885-020-06725-4.","journal-title":"BMC Cancer"},{"key":"620_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40169-015-0048-3","volume":"4","author":"S Heerboth","year":"2015","unstructured":"Heerboth S, et al. EMT and tumor metastasis. Clin Transl Med. 2015;4:6. https:\/\/doi.org\/10.1186\/s40169-015-0048-3.","journal-title":"Clin Transl Med"},{"key":"620_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396. https:\/\/doi.org\/10.1038\/nrm3758.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"620_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1158\/0008-5472.CAN-10-2550","volume":"71","author":"J Wu","year":"2011","unstructured":"Wu J, et al. HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes. Cancer Res. 2011;71:349\u201359. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2550.","journal-title":"Cancer Res"},{"key":"620_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12935-024-03351-z","volume":"24","author":"X Cai","year":"2024","unstructured":"Cai X, et al. CDK4\/6 Inhibition enhances T-cell immunotherapy on hepatocellular carcinoma cells by rejuvenating immunogenicity. Cancer Cell Int. 2024;24:215. https:\/\/doi.org\/10.1186\/s12935-024-03351-z.","journal-title":"Cancer Cell Int"},{"key":"620_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-024-01982-1","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma. Apoptosis. 2024. https:\/\/doi.org\/10.1007\/s10495-024-01982-1.","journal-title":"Apoptosis"},{"key":"620_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41392-021-00784-0","volume":"6","author":"J Chen","year":"2021","unstructured":"Chen J, et al. GOLM1 exacerbates CD8(+) T cell suppression in hepatocellular carcinoma by promoting Exosomal PD-L1 transport into tumor-associated macrophages. Signal Transduct Target Ther. 2021;6:397. https:\/\/doi.org\/10.1038\/s41392-021-00784-0.","journal-title":"Signal Transduct Target Ther"},{"key":"620_CR45","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s00535-023-02008-4","volume":"58","author":"L Yang","year":"2023","unstructured":"Yang L, et al. N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment. J Gastroenterol. 2023;58:718\u201333. https:\/\/doi.org\/10.1007\/s00535-023-02008-4.","journal-title":"J Gastroenterol"},{"key":"620_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7150\/ijbs.50003","volume":"17","author":"XY Pan","year":"2021","unstructured":"Pan XY, Huang C, Li J. The emerging roles of m(6)A modification in liver carcinogenesis. Int J Biol Sci. 2021;17:271\u201384. https:\/\/doi.org\/10.7150\/ijbs.50003.","journal-title":"Int J Biol Sci"},{"key":"620_CR47","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s13577-024-01025-6","volume":"37","author":"L Zhang","year":"2024","unstructured":"Zhang L, Liu X, Zhou S, Wang P, Zhang X. Glycolysis modulation by METTL7B shapes acute lymphoblastic leukemia cell proliferation and chemotherapy response. Hum Cell. 2024;37:478\u201390. https:\/\/doi.org\/10.1007\/s13577-024-01025-6.","journal-title":"Hum Cell"},{"key":"620_CR48","doi-asserted-by":"publisher","unstructured":"Li Z, Song Y, Zhang J. LncRNA PDCD4-AS1 promotes the progression of glioma by regulating miR-30b-3p\/METTL7B signaling. Oxid Med Cell Longev. 2023;2023(3492480). https:\/\/doi.org\/10.1155\/2023\/3492480.","DOI":"10.1155\/2023\/3492480"},{"key":"620_CR49","doi-asserted-by":"publisher","unstructured":"Philipp TM, Scheller AS, Krafczyk N, Klotz LO, Steinbrenner H. Methanethiol: A scent mark of dysregulated sulfur metabolism in Cancer. Antioxid (Basel). 2023;12. https:\/\/doi.org\/10.3390\/antiox12091780.","DOI":"10.3390\/antiox12091780"},{"key":"620_CR50","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2004-04-1653","volume":"104","author":"N Beslu","year":"2004","unstructured":"Beslu N, et al. Molecular interactions involved in HOXB4-induced activation of HSC self-renewal. Blood. 2004;104:2307\u201314. https:\/\/doi.org\/10.1182\/blood-2004-04-1653.","journal-title":"Blood"},{"key":"620_CR51","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1182\/blood-2010-12-323212","volume":"117","author":"M Oshima","year":"2011","unstructured":"Oshima M, et al. Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells. Blood. 2011;117:e142\u2013150. https:\/\/doi.org\/10.1182\/blood-2010-12-323212.","journal-title":"Blood"},{"key":"620_CR52","doi-asserted-by":"publisher","first-page":"16952","DOI":"10.1073\/pnas.0703082104","volume":"104","author":"B Schiedlmeier","year":"2007","unstructured":"Schiedlmeier B, et al. HOXB4\u2019s road map to stem cell expansion. Proc Natl Acad Sci U S A. 2007;104:16952\u20137. https:\/\/doi.org\/10.1073\/pnas.0703082104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"620_CR53","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/cas.16049","volume":"115","author":"J Liu","year":"2024","unstructured":"Liu J, et al. LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits Glycolysis and ovarian cancer progression by destabilizing c-Myc. Cancer Sci. 2024;115:804\u201319. https:\/\/doi.org\/10.1111\/cas.16049.","journal-title":"Cancer Sci"},{"key":"620_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijpsycho.2021.01.001","volume":"161","author":"RJ Macatee","year":"2021","unstructured":"Macatee RJ, et al. Psychometric properties of the late positive potential in combat-exposed veterans. Int J Psychophysiol. 2021;161:13\u201326. https:\/\/doi.org\/10.1016\/j.ijpsycho.2021.01.001.","journal-title":"Int J Psychophysiol"},{"key":"620_CR55","doi-asserted-by":"publisher","first-page":"113607","DOI":"10.1016\/j.biopha.2022.113607","volume":"154","author":"S Hao","year":"2022","unstructured":"Hao S, et al. The role of transketolase in human cancer progression and therapy. Biomed Pharmacother. 2022;154:113607. https:\/\/doi.org\/10.1016\/j.biopha.2022.113607.","journal-title":"Biomed Pharmacother"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-025-00620-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:23:10Z","timestamp":1741191790000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-025-00620-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/s13062-025-00620-3","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the ethical standards of animal care and approved by the Life Science Ethics Review Committee of Zhengzhou University (March 18, 2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}